These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22801586)

  • 1. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.
    Swigris JJ; Han M; Vij R; Noth I; Eisenstein EL; Anstrom KJ; Brown KK; Fairclough D
    Respir Med; 2012 Oct; 106(10):1447-55. PubMed ID: 22801586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.
    Chen T; Tsai APY; Hur SA; Wong AW; Sadatsafavi M; Fisher JH; Johannson KA; Assayag D; Morisset J; Shapera S; Khalil N; Fell CD; Manganas H; Cox G; To T; Gershon AS; Hambly N; Halayko AJ; Wilcox PG; Kolb M; Ryerson CJ
    Respir Res; 2021 Jul; 22(1):202. PubMed ID: 34238283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.
    Swigris JJ; Streiner DL; Brown KK; Belkin A; Green KE; Wamboldt FS;
    Respir Med; 2014 Jan; 108(1):181-8. PubMed ID: 24388667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis.
    Bacci ED; O'Quinn S; Leidy NK; Murray L; Vernon M
    Respir Med; 2018 Jan; 134():130-138. PubMed ID: 29413500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.
    Swigris JJ; Brown KK; Behr J; du Bois RM; King TE; Raghu G; Wamboldt FS
    Respir Med; 2010 Feb; 104(2):296-304. PubMed ID: 19815403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis.
    Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
    Respiration; 2016; 91(6):497-502. PubMed ID: 27240427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis.
    Oğuz MS; Bingöl Z; Pıhtılı A; Karaca Özer P; Sarıtaş Arslan M; Kılıçaslan Z; Bilge AK; Kıyan E; Okumuş G
    BMC Pulm Med; 2024 Jul; 24(1):373. PubMed ID: 39085811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
    Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
    Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Herth FJF; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Frankenberger M; Behr J
    Respir Res; 2017 Jul; 18(1):139. PubMed ID: 28709421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
    O'Brien EC; Hellkamp AS; Neely ML; Swaminathan A; Bender S; Snyder LD; Culver DA; Conoscenti CS; Todd JL; Palmer SM; Leonard TB;
    Chest; 2020 May; 157(5):1188-1198. PubMed ID: 31954102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis.
    Olson AL; Graney B; Baird S; Churney T; Fier K; Korn M; McCormick M; Sprunger D; Vierzba T; Wamboldt FS; Swigris JJ
    BMC Pulm Med; 2017 Nov; 17(1):152. PubMed ID: 29166901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.
    Han MK; Bach DS; Hagan PG; Yow E; Flaherty KR; Toews GB; Anstrom KJ; Martinez FJ;
    Chest; 2013 Jun; 143(6):1699-1708. PubMed ID: 23732584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.
    Kreuter M; Wuyts WA; Wijsenbeek M; Bajwah S; Maher TM; Stowasser S; Male N; Stansen W; Schoof N; Orsatti L; Swigris J
    Respir Res; 2020 Jan; 21(1):36. PubMed ID: 32000772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.
    Ley B; Bradford WZ; Vittinghoff E; Weycker D; du Bois RM; Collard HR
    Am J Respir Crit Care Med; 2016 Sep; 194(6):711-8. PubMed ID: 26938706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis.
    Capparelli I; Fernandez M; Saadia Otero M; Steimberg J; Brassesco M; Campobasso A; Palacios S; Caro F; Alberti ML; Rabinovich RA; Paulin F
    Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):68-73. PubMed ID: 29102341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the IPF-specific version of St. George's Respiratory Questionnaire.
    Prior TS; Hoyer N; Shaker SB; Davidsen JR; Yorke J; Hilberg O; Bendstrup E
    Respir Res; 2019 Aug; 20(1):199. PubMed ID: 31462235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
    Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
    Serajeddini H; Rogliani P; Mura M
    Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.